Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Division for Health Service Promotion, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
J Gastroenterol. 2023 Dec;58(12):1237-1251. doi: 10.1007/s00535-023-02038-y. Epub 2023 Sep 14.
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).
We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.
Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8 PD1 T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8 PD1 T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.
The decreased frequency of peripheral CD8 PD1 T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.
非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)临床上包括自身免疫,表现为抗核抗体(ANA)阳性和自身免疫性肝炎(AIH)重叠。区分 AIH 重叠性 NASH 与 NAFLD/NASH 对于正确治疗是必需的,通常涉及通过侵入性肝活检进行病理诊断。通过流式细胞术(FCM)评估 NAFLD 和 AIH 中外周淋巴细胞的差异模式,以无创方式指示 AIH 重叠性 NASH 的危险因素。
我们评估了 115 例患者的外周淋巴细胞差异频率:70 例 NASH(ANA 阴性:阳性:AIH 重叠=36:20:14),18 例 NAFL 和 27 例 AIH(急性:慢性=12:15)患者由 FCM 诊断。我们重点关注以下淋巴细胞群体:T 细胞、B 细胞、自然杀伤(NK)细胞、NKT 细胞、辅助 T 细胞(Th)亚群(Th1、Th2 和 Th17)和调节性 T 细胞;我们还检查了程序性细胞死亡(PD)1 和细胞毒性 T 淋巴细胞抗原水平。
在 NAFLD 和 AIH 亚组中,实验室参数和外周淋巴细胞频率存在几个显著差异。在单变量和多变量分析中,透明质酸水平、肝硬度以及 Th17 和 CD8 PD1 T 细胞的频率是 NAFLD 中 NASH 的独立危险因素。关于 AIH 的重叠,只有 CD8 PD1 T 细胞的频率(比值比,0.01;95%置信区间 0.00-38.9,p=0.004)是 NASH 的独立危险因素,在 AIH 中显著降低。
本研究队列中,外周 CD8 PD1 T 细胞频率降低是 AIH 重叠性 NASH 的独立危险因素。我们的发现将促进开发一种新的非侵入性 FCM 方法,用于指示包括自身免疫在内的 NASH 的危险因素。